348 related articles for article (PubMed ID: 24498083)
1. β-hairpin-mediated formation of structurally distinct multimers of neurotoxic prion peptides.
Gill AC
PLoS One; 2014; 9(1):e87354. PubMed ID: 24498083
[TBL] [Abstract][Full Text] [Related]
2. Molecular structures of amyloid and prion fibrils: consensus versus controversy.
Tycko R; Wickner RB
Acc Chem Res; 2013 Jul; 46(7):1487-96. PubMed ID: 23294335
[TBL] [Abstract][Full Text] [Related]
3. Direct observation of protein folding, aggregation, and a prion-like conformational conversion.
Ding F; LaRocque JJ; Dokholyan NV
J Biol Chem; 2005 Dec; 280(48):40235-40. PubMed ID: 16204250
[TBL] [Abstract][Full Text] [Related]
4. Structural stability and dynamics of an amyloid-forming peptide GNNQQNY from the yeast prion sup-35.
Zheng J; Ma B; Tsai CJ; Nussinov R
Biophys J; 2006 Aug; 91(3):824-33. PubMed ID: 16679374
[TBL] [Abstract][Full Text] [Related]
5. Molecular origin of Gerstmann-Sträussler-Scheinker syndrome: insight from computer simulation of an amyloidogenic prion peptide.
Daidone I; Di Nola A; Smith JC
Biophys J; 2011 Jun; 100(12):3000-7. PubMed ID: 21689534
[TBL] [Abstract][Full Text] [Related]
6. Role of water in protein aggregation and amyloid polymorphism.
Thirumalai D; Reddy G; Straub JE
Acc Chem Res; 2012 Jan; 45(1):83-92. PubMed ID: 21761818
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
8. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
9. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
10. Effects of the A117V mutation on the folding and aggregation of palindromic sequences (PrP113-120) in prion: insights from replica exchange molecular dynamics simulations.
Ning L; Wang Q; Zheng Y; Liu H; Yao X
Mol Biosyst; 2015 Feb; 11(2):647-55. PubMed ID: 25483828
[TBL] [Abstract][Full Text] [Related]
11. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
12. Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach.
Rosenman DJ; Connors CR; Chen W; Wang C; García AE
J Mol Biol; 2013 Sep; 425(18):3338-59. PubMed ID: 23811057
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
14. Conformational stability of fibrillar amyloid-beta oligomers via protofilament pair formation - a systematic computational study.
Kahler A; Sticht H; Horn AH
PLoS One; 2013; 8(7):e70521. PubMed ID: 23936224
[TBL] [Abstract][Full Text] [Related]
15. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).
Saracino GA; Villa A; Moro G; Cosentino U; Salmona M
Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953
[TBL] [Abstract][Full Text] [Related]
17. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M
J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586
[TBL] [Abstract][Full Text] [Related]
18. Hetero-oligomeric Amyloid Assembly and Mechanism: Prion Fragment PrP(106-126) Catalyzes the Islet Amyloid Polypeptide β-Hairpin.
Ilitchev AI; Giammona MJ; Olivas C; Claud SL; Lazar Cantrell KL; Wu C; Buratto SK; Bowers MT
J Am Chem Soc; 2018 Aug; 140(30):9685-9695. PubMed ID: 29989407
[TBL] [Abstract][Full Text] [Related]
19. Defining the pathway of worm-like amyloid fibril formation by the mouse prion protein by delineation of the productive and unproductive oligomerization reactions.
Jain S; Udgaonkar JB
Biochemistry; 2011 Feb; 50(7):1153-61. PubMed ID: 21214263
[TBL] [Abstract][Full Text] [Related]
20. Critical region for amyloid fibril formation of mouse prion protein: unusual amyloidogenic properties of the helix 2 peptide.
Yamaguchi K; Matsumoto T; Kuwata K
Biochemistry; 2008 Dec; 47(50):13242-51. PubMed ID: 19053276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
